The Peptide Directory

FDA-approvedMelanocortin agonistSexual desire (women)

PT-141 (bremelanotide)

PT-141 (bremelanotide) is a melanocortin-receptor agonist, FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women.

Last reviewed by The Peptide Directory Editorial Team

What is PT-141?

PT-141 (bremelanotide) is a melanocortin-receptor agonist, FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. PT-141 (bremelanotide) is an FDA-approved prescription medicine (VYLEESI (AUTOINJECTOR)); "research use only" vials sold online are not the approved product.

Key takeaways

  1. PT-141 (bremelanotide) is an FDA-approved prescription medicine (VYLEESI (AUTOINJECTOR)); "research use only" vials sold online are not the approved product.
  2. PubMed indexes 95 papers on PT-141 (11 tagged as clinical trials) as of October 19, 2026.
  3. ClinicalTrials.gov lists 10 registered studies using PT-141.
  4. 39 vendors in our directory listed PT-141 in their public catalog on October 19, 2026.

Structure

2D chemical structure of PT-141 (C50H68N14O10), as depicted by PubChem
Structure: PubChem CID 9941379 (C50H68N14O10, 1,025.2 g/mol). 2D depiction from NCBI PubChem, retrieved October 19, 2026.

Regulatory & access status

PT-141 (bremelanotide) is an FDA-approved prescription medicine (VYLEESI (AUTOINJECTOR)); "research use only" vials sold online are not the approved product.

  • VYLEESI (AUTOINJECTOR) — COSETTE, application NDA210557 (prescription). Drugs@FDA

Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.

How much research exists on PT-141 (bremelanotide)?

PubMed indexes 95 papers mentioning PT-141 (bremelanotide) in the title or abstract, 52 of them from the last five years and 11 tagged as clinical trials (search run October 19, 2026; repeat the search).

Most relevant recent papers

Registered clinical studies

ClinicalTrials.gov lists 10 studies with PT-141 (bremelanotide) as an intervention (see all). Most recent:

What the evidence does not show

  • Paper counts measure research attention, not whether PT-141 works or is safe.

Research suppliers that list PT-141

39 vendors in our directory listed a product matching PT-141 in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.

Prices per mg, where we could verify them, are on our price comparison.

PT-141 reconstitution math

Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.

PT-141 FAQ

Is PT-141 FDA-approved?

PT-141 (bremelanotide) is an FDA-approved prescription medicine (VYLEESI (AUTOINJECTOR)); "research use only" vials sold online are not the approved product.

Is PT-141 safe?

Safety data come from the published studies listed on this page; read them in full. Products sold as "research use only" have no FDA review of their purity, sterility or dose.

How much research is there on PT-141?

PubMed indexes 95 papers on PT-141 (11 tagged as clinical trials) as of October 19, 2026.

Who sells PT-141?

Amino Amigos, Ascension Peptides, Atomik Labz, Backroad Aminos, Biocollex Research, BioGenix Peptides and 33 more listed it on their public catalogs when we checked; a listing is not an endorsement.

Head-to-head comparisons

PT-141 vs Melanotan II

Related compounds

OxytocinhCGTriptorelinKisspeptin-10GonadorelinMelanotan IIhMGProstamaxAll sexual & reproductive health